1. Home
  2. MDWD
  3. MDWD News

Latest MediWound Ltd. (MDWD) News on August 30, 2025

MDWD

MT Newswires

3 months ago

Oppenheimer Adjusts MediWound Price Target to $34 From $36, Maintains Outperform Rating

Companies Like MediWound (NASDAQ:MDWD) Are In A Position To Invest In Growth
MDWD

Simply Wall St.

3 months ago

Companies Like MediWound (NASDAQ:MDWD) Are In A Position To Invest In Growth

MediWound Ltd (MDWD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Decline
MDWD

GuruFocus.com

3 months ago

MediWound Ltd (MDWD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Decline

MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates
MDWD

Zacks

3 months ago

MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates

MDWD

Associated Press Finance

3 months ago

MediWound: Q1 Earnings Snapshot

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update
MDWD

GlobeNewswire

3 months ago

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update

Earnings To Watch: MediWound Ltd (MDWD) Reports Q1 2025 Result
MDWD

GuruFocus.com

3 months ago

Earnings To Watch: MediWound Ltd (MDWD) Reports Q1 2025 Result

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers
MDWD

GlobeNewswire

4 months ago

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers

MediWound to Report First Quarter 2025 Financial Results
MDWD

GlobeNewswire

4 months ago

MediWound to Report First Quarter 2025 Financial Results

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
MDWD

GlobeNewswire

4 months ago

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

Those who invested in MediWound (NASDAQ:MDWD) five years ago are up 30%
MDWD

Simply Wall St.

4 months ago

Those who invested in MediWound (NASDAQ:MDWD) five years ago are up 30%

MediWound Ltd (MDWD) Q4 2024 Earnings Report Preview: What To Look For
MDWD

GuruFocus.com

5 months ago

MediWound Ltd (MDWD) Q4 2024 Earnings Report Preview: What To Look For

Loss-Making MediWound Ltd. (NASDAQ:MDWD) Expected To Breakeven In The Medium-Term
MDWD

Simply Wall St.

5 months ago

Loss-Making MediWound Ltd. (NASDAQ:MDWD) Expected To Breakeven In The Medium-Term

MediWound Ltd (MDWD) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Losses
MDWD

GuruFocus.com

5 months ago

MediWound Ltd (MDWD) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Losses

MDWD

MT Newswires

5 months ago

MediWound Files for $125 Million Mixed Shelf

MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates
MDWD

Zacks

5 months ago

MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates

MDWD

MT Newswires

5 months ago

Top Premarket Gainers

MDWD

Associated Press Finance

5 months ago

MediWound: Q4 Earnings Snapshot

MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
MDWD

GlobeNewswire

5 months ago

MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results
MDWD

GlobeNewswire

6 months ago

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results

Madrigal (MDGL) Reports Q4 Loss, Tops Revenue Estimates
MDWD

Zacks

6 months ago

Madrigal (MDGL) Reports Q4 Loss, Tops Revenue Estimates

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care
MDWD

GlobeNewswire

6 months ago

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care

MediWound to Present at the 45th Annual TD Cowen Health Care Conference
MDWD

GlobeNewswire

6 months ago

MediWound to Present at the 45th Annual TD Cowen Health Care Conference

MediWound commences Phase III trial for venous leg ulcers treatment
MDWD

Clinical Trials Arena

7 months ago

MediWound commences Phase III trial for venous leg ulcers treatment

MDWD

MT Newswires

7 months ago

MediWound Launches Phase III Trial Evaluating EscharEx for Treating Venous Leg Ulcers

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers
MDWD

GlobeNewswire

7 months ago

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

MediWound to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
MDWD

GlobeNewswire

7 months ago

MediWound to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

MediWound Ltd.'s (NASDAQ:MDWD) high institutional ownership speaks for itself as stock continues to impress, up 15% over last week
MDWD

Simply Wall St.

7 months ago

MediWound Ltd.'s (NASDAQ:MDWD) high institutional ownership speaks for itself as stock continues to impress, up 15% over last week

MediWound (MDWD) Surges 8.5%: Is This an Indication of Further Gains?
MDWD

Zacks

7 months ago

MediWound (MDWD) Surges 8.5%: Is This an Indication of Further Gains?

Mediwound Advances in Enzymatic Therapeutics with Strategic Expansions
MDWD

TipRanks

8 months ago

Mediwound Advances in Enzymatic Therapeutics with Strategic Expansions

We're Keeping An Eye On MediWound's (NASDAQ:MDWD) Cash Burn Rate
MDWD

Simply Wall St.

8 months ago

We're Keeping An Eye On MediWound's (NASDAQ:MDWD) Cash Burn Rate

MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx® Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025
MDWD

GlobeNewswire

8 months ago

MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx® Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025

MediWound Executives Acquire 18,462 Shares, Signaling Confidence in Company’s Future
MDWD

TipRanks

8 months ago

MediWound Executives Acquire 18,462 Shares, Signaling Confidence in Company’s Future

MediWound Third Quarter 2024 Earnings: Misses Expectations
MDWD

Simply Wall St.

9 months ago

MediWound Third Quarter 2024 Earnings: Misses Expectations

MediWound Ltd (MDWD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
MDWD

GuruFocus.com

9 months ago

MediWound Ltd (MDWD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

MediWound (MDWD) Reports Q3 Loss, Lags Revenue Estimates
MDWD

Zacks

9 months ago

MediWound (MDWD) Reports Q3 Loss, Lags Revenue Estimates

MDWD

Associated Press Finance

9 months ago

MediWound: Q3 Earnings Snapshot

MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update
MDWD

GlobeNewswire

9 months ago

MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update

What To Expect From MediWound Ltd (MDWD) Q3 2024 Earnings
MDWD

GuruFocus.com

9 months ago

What To Expect From MediWound Ltd (MDWD) Q3 2024 Earnings

MediWound to Report Third Quarter 2024 Financial Results
MDWD

GlobeNewswire

10 months ago

MediWound to Report Third Quarter 2024 Financial Results

MediWound's (NASDAQ:MDWD) investors will be pleased with their stellar 125% return over the last year
MDWD

Simply Wall St.

10 months ago

MediWound's (NASDAQ:MDWD) investors will be pleased with their stellar 125% return over the last year

Rosalind Advisors, Inc. Increases Stake in MediWound Ltd
MDWD

GuruFocus.com

10 months ago

Rosalind Advisors, Inc. Increases Stake in MediWound Ltd

MDWD

MT Newswires

a year ago

MediWound to Begin Phase II Study of EscharEx Versus Collagenase in Venous Leg Ulcer Patients

MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers
MDWD

GlobeNewswire

a year ago

MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers

MediWound to Participate in the 2024 Maxim Healthcare Virtual Summit
MDWD

GlobeNewswire

a year ago

MediWound to Participate in the 2024 Maxim Healthcare Virtual Summit

MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference
MDWD

GlobeNewswire

a year ago

MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference

MediWound Ltd.'s (NASDAQ:MDWD) top owners are retail investors with 38% stake, while 28% is held by institutions
MDWD

Simply Wall St.

a year ago

MediWound Ltd.'s (NASDAQ:MDWD) top owners are retail investors with 38% stake, while 28% is held by institutions

MediWound and Vericel win FDA paediatric label expansion for NexoBrid
MDWD

Medical Device Network

a year ago

MediWound and Vericel win FDA paediatric label expansion for NexoBrid

MDWD

MT Newswires

a year ago

MediWound Gets FDA Approval for Severe Thermal Burn Treatment for Pediatric Patients

MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns
MDWD

GlobeNewswire

a year ago

MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns

MediWound (MDWD) Reports Q2 Loss, Lags Revenue Estimates
MDWD

Zacks

a year ago

MediWound (MDWD) Reports Q2 Loss, Lags Revenue Estimates

MDWD

Associated Press Finance

a year ago

MediWound: Q2 Earnings Snapshot

MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update
MDWD

GlobeNewswire

a year ago

MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update

Harrow (HROW) Reports Q2 Loss, Tops Revenue Estimates
MDWD

Zacks

a year ago

Harrow (HROW) Reports Q2 Loss, Tops Revenue Estimates

MediWound (MDWD) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
MDWD

Zacks

a year ago

MediWound (MDWD) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)
MDWD

GlobeNewswire

a year ago

MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)

MediWound to Report Second Quarter 2024 Financial Results
MDWD

GlobeNewswire

a year ago

MediWound to Report Second Quarter 2024 Financial Results

Can MediWound (MDWD) Climb 57.49% to Reach the Level Wall Street Analysts Expect?
MDWD

Zacks

a year ago

Can MediWound (MDWD) Climb 57.49% to Reach the Level Wall Street Analysts Expect?

MediWound reinforces wound therapy EscharEx data ahead of Phase III trial
MDWD

Medical Device Network

a year ago

MediWound reinforces wound therapy EscharEx data ahead of Phase III trial

MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers
MDWD

GlobeNewswire

a year ago

MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers

MDWD

MT Newswires

a year ago

MediWound to Receive Around $18 Million in Financing From European Innovation Council

MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program
MDWD

GlobeNewswire

a year ago

MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program

MDWD

MT Newswires

a year ago

Sector Update: Health Care Stocks Edge Higher Premarket Monday

MDWD

MT Newswires

a year ago

MediWound Launches $25 Million Private Placement

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd
MDWD

PR Newswire

a year ago

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

MediWound Announces $25 Million Strategic Private Placement Financing
MDWD

GlobeNewswire

a year ago

MediWound Announces $25 Million Strategic Private Placement Financing

Is MediWound (NASDAQ:MDWD) In A Good Position To Invest In Growth?
MDWD

Simply Wall St.

a year ago

Is MediWound (NASDAQ:MDWD) In A Good Position To Invest In Growth?

Earnings Update: MediWound Ltd. (NASDAQ:MDWD) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
MDWD

Simply Wall St.

a year ago

Earnings Update: MediWound Ltd. (NASDAQ:MDWD) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates
MDWD

Zacks

a year ago

MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates

MDWD

Associated Press Finance

a year ago

MediWound: Q1 Earnings Snapshot

MediWound Reports First Quarter 2024 Financial Results and Provides Company Update
MDWD

GlobeNewswire

a year ago

MediWound Reports First Quarter 2024 Financial Results and Provides Company Update

MediWound to Report First Quarter 2024 Financial Results
MDWD

GlobeNewswire

a year ago

MediWound to Report First Quarter 2024 Financial Results

Investors in MediWound (NASDAQ:MDWD) have seen decent returns of 65% over the past year
MDWD

Simply Wall St.

a year ago

Investors in MediWound (NASDAQ:MDWD) have seen decent returns of 65% over the past year

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences
MDWD

GlobeNewswire

a year ago

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences

Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
MDWD

Zacks

a year ago

Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?

Wall Street Analysts See a 76.89% Upside in MediWound (MDWD): Can the Stock Really Move This High?
MDWD

Zacks

a year ago

Wall Street Analysts See a 76.89% Upside in MediWound (MDWD): Can the Stock Really Move This High?

What Makes MediWound (MDWD) a Good Fit for 'Trend Investing'
MDWD

Zacks

a year ago

What Makes MediWound (MDWD) a Good Fit for 'Trend Investing'

MediWound Ltd. (NASDAQ:MDWD) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
MDWD

Simply Wall St.

a year ago

MediWound Ltd. (NASDAQ:MDWD) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates
MDWD

Zacks

a year ago

MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates

MDWD

Associated Press Finance

a year ago

MediWound: Q4 Earnings Snapshot

MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
MDWD

GlobeNewswire

a year ago

MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

MediWound to Report Fourth Quarter and Full Year 2023 Financial Results
MDWD

GlobeNewswire

a year ago

MediWound to Report Fourth Quarter and Full Year 2023 Financial Results

Retail investors who hold 38% of MediWound Ltd. (NASDAQ:MDWD) gained 15%, institutions profited as well
MDWD

Simply Wall St.

a year ago

Retail investors who hold 38% of MediWound Ltd. (NASDAQ:MDWD) gained 15%, institutions profited as well

MediWound (MDWD) Moves 7.1% Higher: Will This Strength Last?
MDWD

Zacks

a year ago

MediWound (MDWD) Moves 7.1% Higher: Will This Strength Last?

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study
MDWD

GlobeNewswire

2 years ago

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

MediWound to Participate in Two Upcoming Investor Conferences
MDWD

GlobeNewswire

2 years ago

MediWound to Participate in Two Upcoming Investor Conferences

Here's Why We're Not Too Worried About MediWound's (NASDAQ:MDWD) Cash Burn Situation
MDWD

Simply Wall St.

2 years ago

Here's Why We're Not Too Worried About MediWound's (NASDAQ:MDWD) Cash Burn Situation

High Tide To Open First Canna Cabana Store in Fort McMurray, Alberta
MDWD

PR Newswire

2 years ago

High Tide To Open First Canna Cabana Store in Fort McMurray, Alberta

EPIX: Updated Data for Phase 1 Trial of Masofaniten Shows 63% of Patients Achieved PSA <0.2 ng/mL…
MDWD

Zacks Small Cap Research

2 years ago

EPIX: Updated Data for Phase 1 Trial of Masofaniten Shows 63% of Patients Achieved PSA <0.2 ng/mL…

Heritage Commerce Corp Earns $13.3 Million for the Fourth Quarter of 2023, and $64.4 Million for the Full Year 2023
MDWD

GlobeNewswire

2 years ago

Heritage Commerce Corp Earns $13.3 Million for the Fourth Quarter of 2023, and $64.4 Million for the Full Year 2023

Investar Holding Corp Reports Mixed Q4 Results Amid Strategic Balance Sheet Optimization
MDWD

GuruFocus.com

2 years ago

Investar Holding Corp Reports Mixed Q4 Results Amid Strategic Balance Sheet Optimization

MDWD

Associated Press Finance

2 years ago

Investar: Q4 Earnings Snapshot

Investar Holding Corporation Announces 2023 Fourth Quarter Results
MDWD

ACCESSWIRE

2 years ago

Investar Holding Corporation Announces 2023 Fourth Quarter Results

AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
MDWD

Business Wire

2 years ago

AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease

Largo Reports Fourth Quarter and Full Year 2023 Operational and Sales Results Highlighted by Record Quarterly High Purity V2O5 Production; Provides 2024 Guidance
MDWD

Business Wire

2 years ago

Largo Reports Fourth Quarter and Full Year 2023 Operational and Sales Results Highlighted by Record Quarterly High Purity V2O5 Production; Provides 2024 Guidance

Relmada Therapeutics, Inc.'s (NASDAQ:RLMD) market cap touched US$109m last week, benefiting both individual investors who own 39% as well as institutions
MDWD

Simply Wall St.

2 years ago

Relmada Therapeutics, Inc.'s (NASDAQ:RLMD) market cap touched US$109m last week, benefiting both individual investors who own 39% as well as institutions

Willdan Selected for Sixth Consecutive Time to Deliver Puget Sound Energy Small Business Program
MDWD

Business Wire

2 years ago

Willdan Selected for Sixth Consecutive Time to Deliver Puget Sound Energy Small Business Program

Safety Shot Responds to FSD Pharma’s 3rd unauthorized Tagging of its Stock and Making False Claims in an Effort to Harm the Company and its Shareholders
MDWD

GlobeNewswire

2 years ago

Safety Shot Responds to FSD Pharma’s 3rd unauthorized Tagging of its Stock and Making False Claims in an Effort to Harm the Company and its Shareholders

Litigation Update - Safety Shot Authorized to Serve Notice of Action Against Capybara Research and Igor Appelboom by Public Disclosure and Press Release Pursuant to Court Order
MDWD

GlobeNewswire

2 years ago

Litigation Update - Safety Shot Authorized to Serve Notice of Action Against Capybara Research and Igor Appelboom by Public Disclosure and Press Release Pursuant to Court Order

FingerMotion Reports Q3 2024 Financial Results
MDWD

ACCESSWIRE

2 years ago

FingerMotion Reports Q3 2024 Financial Results

Share on Social Networks: